| The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis DA Koutoukidis, SA Jebb, M Zimmerman, A Otunla, JA Henry, A Ferrey, ... Gut microbes 14 (1), 2020068, 2022 | 75 | 2022 |
| Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: a systematic review of reviews J Hartmann-Boyce, K Rees, JC Perring, SA Kerneis, EM Morris, C Goyder, ... Diabetes Care 44 (12), 2790-2811, 2021 | 71 | 2021 |
| Asthma and COVID-19: review of evidence on risks and management considerations J Hartmann-Boyce, J Gunnell, J Drake, A Otunla, J Suklan, E Schofield, ... BMJ Evidence-Based Medicine 26 (4), 195-195, 2021 | 65 | 2021 |
| The impact of the COVID19 pandemic on Glycaemic control in people with diabetes: A systematic review and MetaAnalysis LL O'Mahoney, PJ Highton, L Kudlek, J Morgan, R Lynch, E Schofield, ... Diabetes, Obesity and Metabolism 24 (9), 1850-1860, 2022 | 32 | 2022 |
| Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses A Otunla, K Rees, P Dennison, R Hobbs, J Suklan, E Schofield, J Gunnell, ... BMJ Evidence-Based Medicine 27 (5), 263-273, 2022 | 15 | 2022 |
| Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evid Based Med. 2020 J Hartmann-Boyce, J Gunnell, J Drake, A Otunla, J Suklan, E Schofield, ... | 6 | |
| Chronic Rejection and Atherosclerosis in Post-Transplant Cardiovascular Mortality: Two Sides of the Same Coin AA Otunla, K Shanmugarajah, ML Madariaga, AH Davies, J Shalhoub Heart, Lung and Circulation 31 (2), 162-166, 2022 | 4 | 2022 |
| Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions AA Otunla, K Shanmugarajah, AH Davies, J Shalhoub Frontiers in Pharmacology 15, 1355674, 2024 | 2 | 2024 |
| An update to the overview of reviews: risks of and from SARS-COV-2 infection and COVID-19 in people with diabetes J Hartmann-Boyce, K Rees, I Onakpoya, A Otunla, E Morris, J Morgan, ... Diabetes Care 46 (12), e215-e216, 2023 | 1 | 2023 |
| Symptomatic atherosclerotic vascular disease and graft survival in primary kidney transplant recipients–Observational analysis of the united network of organ sharing database AA Otunla, K Shanmugarajah, JD Salciccioli, DC Marshall, AH Davies, ... Transplant Immunology 75, 101734, 2022 | 1 | 2022 |
| The influence of HLA matching on graft survival in lung transplant recipients is indication specific A Otunla, K Shanmugarajah, S Nabulsi, J Salciccioli, G Mukhtar, D Dolan, ... European Respiratory Journal 64 (suppl 68), 2024 | | 2024 |
| O6 HLA-A matching influences clinical liver transplant graft survival in an indication specific fashion A Otunla, S Nabulsi, J Salciccioli, D Marshall, K Shanmugarajah, ... Gut 73 (Suppl 3), A2-A3, 2024 | | 2024 |
| Clinical trials of pharmacological interventions for SARSCoV2 published in leading medical journals report adherence but not how it was assessed C Lee, A Otunla, I Brennan, JK Aronson, D Nunan British Journal of Clinical Pharmacology 90 (4), 1130-1141, 2024 | | 2024 |
| O236: The Impact of HLA Matching on Pancreas and Simultaneous Pancreas-Kidney (SPK) Transplantation Outcomes S Nabulsi, A Otunla, J Salciccioli, D Marshall, V Villani, K Shanmugarajah, ... British Journal of Surgery 111 (Supplement_2), znae046. 015, 2024 | | 2024 |
| O203: HLA Matching Between Donors and Recipients Improves Clinical Liver Transplant Graft Survival A Otunla, S Nabulsi, J Salciccioli, D Marshall, V Villani, K Shanmugarajah, ... British Journal of Surgery 111 (Supplement_2), znae046. 008, 2024 | | 2024 |
| O204: The influence of HLA matching on graft survival in lung transplant recipients is indication specific: An UNOS database analysis A Otunla, K Shanmugarajah, G Mukhtar, S Nabulsi, D Dolan, J Salciccioli, ... British Journal of Surgery 111 (Supplement_2), znae046. 102, 2024 | | 2024 |
| HLA matching between donors and recipients improves clinical liver transplant graft survival S Nabulsi, AA Otunla, J Salciccioli, DC Marshall, V Villani, ... Liver International 44 (2), 411-421, 2024 | | 2024 |
| Reporting of medication adherence in randomized controlled trials of pharmacological interventions for SARS-CoV-2: a cross-sectional analysis CK Lee, A Otunla, JK Aronson, D Nunan medRxiv, 2022.10. 30.22281709, 2022 | | 2022 |
| WE2. 4 Optimal timing of Laparoscopic Cholecystectomy for symptomatic gallstone disease: the importance of symptom duration A Dey, N Lal, A Otunla, S Singh, J Gilmour British Journal of Surgery 109 (Supplement_5), znac248. 101, 2022 | | 2022 |
| 134 Compliance of randomized control trials investigating pharmacological interventions for SARS-CoV-2 with medication adherence reporting standards: a cross sectional analysis C Lee, D Nunan, J Aronson, A Otunla, I Brennan BMJ Evidence-Based Medicine 27 (Suppl 2), A10-A11, 2022 | | 2022 |
